{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:44:47Z","timestamp":1794091487792,"version":"4.8.0"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian Government Research Training Program Scholarship"},{"DOI":"10.13039\/501100001039","name":"Neurosurgical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001039","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Government Medical Research Future Fund","award":["ID: 2020\/MRF1202188"],"award-info":[{"award-number":["ID: 2020\/MRF1202188"]}]},{"DOI":"10.13039\/501100001786","name":"The University of Adelaide","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Development of Parkinson\u2019s Disease (PD) is linked with a history of traumatic brain injury (TBI), although the mechanisms driving this remain unclear. Of note, many key parallels have been identified between the pathologies of PD and TBI; in particular, PD is characterised by loss of dopaminergic neurons from the substantia nigra (SN), accompanied by broader changes to dopaminergic signalling, disruption of the Locus Coeruleus (LC) and noradrenergic system, and accumulation of aggregated \u03b1-synuclein in Lewy Bodies, which spreads in a stereotypical pattern throughout the brain. Widespread disruptions to the dopaminergic and noradrenergic systems, including progressive neuronal loss from the SN and LC, have been observed acutely following injury, some of which have also been identified chronically in TBI patients and preclinical models<jats:bold>.<\/jats:bold> Furthermore, changes to \u03b1-synuclein expression are also seen both acutely and chronically following injury throughout the brain, although detailed characterisation of these changes and spread of pathology is limited. In this review, we detail the current literature regarding dopaminergic and noradrenergic disruption and \u03b1-synuclein pathology following injury, with particular focus on how these changes may predispose individuals to prolonged pathology and progressive neurodegeneration, particularly the development of PD. While it is increasingly clear that TBI is a key risk factor for the development of PD, significant gaps remain in current understanding of neurodegenerative pathology following TBI, particularly chronic manifestations of injury.<\/jats:p>","DOI":"10.1007\/s12035-025-04706-x","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:00:45Z","timestamp":1738404045000},"page":"7421-7444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lasting Impact: Exploring the Brain Mechanisms that Link Traumatic Brain Injury to Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Samantha","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-7600","authenticated-orcid":false,"given":"Lyndsey","family":"Collins-Praino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"4706_CR1","doi-asserted-by":"publisher","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H, Wang Z (2021) Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson\u2019s Disease in 204 Countries\/Territories From 1990 to 2019. Front Public Health 9:776847. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","journal-title":"Front Public Health"},{"key":"4706_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D (2014) Ageing and Parkinson\u2019s disease: Why is advancing age the biggest risk factor? Ageing Res. Rev 14:19\u201330. https:\/\/doi.org\/10.1016\/j.arr.2014.01.004","journal-title":"Rev"},{"issue":"11","key":"4706_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E et al (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"4706_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the parkinson pandemic. J Parkinsons Dis 8:S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"4706_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0891988712464823","volume":"25","author":"I Leroi","year":"2012","unstructured":"Leroi I, McDonald K, Pantula H, Harbishettar V (2012) Cognitive Impairment in Parkinson Disease: Impact on Quality of Life, Disability, and Caregiver Burden. J Geriatr Psychiatry Neurol 25(4):208\u2013214. https:\/\/doi.org\/10.1177\/0891988712464823","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"4706_CR6","doi-asserted-by":"publisher","unstructured":"Ding, C, Wu, Y, Chen, X et al (2022) Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990\u20132019. Frontiers in Public Health 10.https:\/\/doi.org\/10.3389\/fpubh.2022.952161.","DOI":"10.3389\/fpubh.2022.952161"},{"issue":"3","key":"4706_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5014\/ajot.2014.010330","volume":"68","author":"ER Foster","year":"2014","unstructured":"Foster ER (2014) Instrumental Activities of Daily Living Performance Among People With Parkinson\u2019s Disease Without Dementia. Am J Occup Ther 68(3):353\u2013362. https:\/\/doi.org\/10.5014\/ajot.2014.010330","journal-title":"Am J Occup Ther"},{"issue":"8","key":"4706_CR8","doi-asserted-by":"publisher","first-page":"e0200990","DOI":"10.1371\/journal.pone.0200990","volume":"13","author":"A Beyle","year":"2018","unstructured":"Beyle A, Glonnegger H, Cerff B, Gr\u00e4ber S, Berg D, Liepelt-Scarfone I (2018) The Multiple Object Test as a performance-based tool to assess the decline of ADL function in Parkinson\u2019s disease. PLoS ONE 13(8):e0200990. https:\/\/doi.org\/10.1371\/journal.pone.0200990","journal-title":"PLoS ONE"},{"key":"4706_CR9","doi-asserted-by":"publisher","unstructured":"Yang, W, Hamilton, JL, Kopil, C et al (2020) Current and projected future economic burden of Parkinson's disease in the U.S. NPJ Parkinsons Dis 6: 15.https:\/\/doi.org\/10.1038\/s41531-020-0117-1.","DOI":"10.1038\/s41531-020-0117-1"},{"key":"4706_CR10","doi-asserted-by":"publisher","first-page":"760518","DOI":"10.3389\/fneur.2021.760518","volume":"12","author":"M Garon","year":"2021","unstructured":"Garon M, Weis L, Fiorenzato E et al (2021) Quantification of Brain \u03b2-Amyloid Load in Parkinson\u2019s Disease With Mild Cognitive Impairment: A PET\/MRI Study. Front Neurol 12:760518. https:\/\/doi.org\/10.3389\/fneur.2021.760518","journal-title":"Front Neurol"},{"key":"4706_CR11","doi-asserted-by":"publisher","first-page":"1145939","DOI":"10.3389\/fneur.2023.1145939","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Jin J, Su D, Feng T, Zhao H (2023) Tau-PET imaging in Parkinson\u2019s disease: a systematic review and meta-analysis. Front Neurol 14:1145939. https:\/\/doi.org\/10.3389\/fneur.2023.1145939","journal-title":"Front Neurol"},{"issue":"1","key":"4706_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0301-0082(99)00067-2","volume":"62","author":"F Blandini","year":"2000","unstructured":"Blandini F, Nappi G, Tassorelli C, Martignoni E (2000) Functional changes of the basal ganglia circuitry in Parkinson\u2019s disease. Prog Neurobiol 62(1):63\u201388. https:\/\/doi.org\/10.1016\/s0301-0082(99)00067-2","journal-title":"Prog Neurobiol"},{"issue":"2 Suppl","key":"4706_CR13","first-page":"S40","volume":"14","author":"D Weintraub","year":"2008","unstructured":"Weintraub D, Comella CL, Horn S (2008) Parkinson\u2019s disease\u2013Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. Am J Manag Care 14(2 Suppl):S40\u2013S48","journal-title":"Am J Manag Care"},{"issue":"2","key":"4706_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"issue":"7","key":"4706_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AH Schapira","year":"2017","unstructured":"Schapira AH, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"4706_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL (2008) The Sydney multicenter study of Parkinson\u2019s disease: The inevitability of dementia at 20 years. Mov Disord 23(6):837\u2013844. https:\/\/doi.org\/10.1002\/mds.21956","journal-title":"Mov Disord"},{"issue":"3\u20134","key":"4706_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000353560","volume":"41","author":"I Liepelt-Scarfone","year":"2013","unstructured":"Liepelt-Scarfone I, Gauss K, Maetzler W et al (2013) Evaluation of Progression Markers in the Premotor Phase of Parkinson\u2019s Disease: The Progression Markers in the Premotor Phase Study. Neuroepidemiology 41(3\u20134):174\u2013182. https:\/\/doi.org\/10.1159\/000353560","journal-title":"Neuroepidemiology"},{"issue":"12","key":"4706_CR18","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30(12):1600\u20131609","journal-title":"Mov Disord"},{"issue":"10","key":"4706_CR19","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB (2019) Update of the MDS Research Criteria for Prodromal Parkinson\u2019s Disease. Mov Disord 34(10):1464\u20131470. https:\/\/doi.org\/10.1002\/mds.27802","journal-title":"Mov Disord"},{"issue":"9","key":"4706_CR20","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/mds.27792","volume":"34","author":"MI Maraki","year":"2019","unstructured":"Maraki MI, Stefanis L, Yannakoulia M et al (2019) Motor function and the probability of prodromal Parkinson\u2019s disease in older adults. Mov Disord 34(9):1345\u20131353. https:\/\/doi.org\/10.1002\/mds.27792","journal-title":"Mov Disord"},{"issue":"3","key":"4706_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","volume":"110","author":"L Marinova-Mutafchieva","year":"2009","unstructured":"Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis JB, Medhurst AD, Dexter DT (2009) Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson\u2019s disease. J Neurochem 110(3):966\u2013975. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06189.x","journal-title":"J Neurochem"},{"issue":"3","key":"4706_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AHV Schapira","year":"1990","unstructured":"Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex i deficiency in parkinson\u2019s disease. J Neurochem 54(3):823\u2013827. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb02325.x","journal-title":"J Neurochem"},{"issue":"7","key":"4706_CR23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","volume":"38","author":"M Ikawa","year":"2011","unstructured":"Ikawa M, Okazawa H, Kudo T, Kuriyama M, Fujibayashi Y, Yoneda M (2011) Evaluation of striatal oxidative stress in patients with Parkinson\u2019s disease using [62Cu]ATSM PET. Nucl Med Biol 38(7):945\u2013951. https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.02.016","journal-title":"Nucl Med Biol"},{"issue":"1","key":"4706_CR24","doi-asserted-by":"publisher","first-page":"e0146129","DOI":"10.1371\/journal.pone.0146129","volume":"11","author":"MS Medeiros","year":"2016","unstructured":"Medeiros MS, Schumacher-Schuh A, Cardoso AM et al (2016) Iron and oxidative stress in parkinson\u2019s disease: an observational study of injury biomarkers. PLoS ONE 11(1):e0146129. https:\/\/doi.org\/10.1371\/journal.pone.0146129","journal-title":"PLoS ONE"},{"issue":"1","key":"4706_CR25","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1111\/ejn.12205","volume":"38","author":"I Morales","year":"2013","unstructured":"Morales I, Sabate M, Rodriguez M (2013) Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson\u2019s disease. Eur J Neurosci 38(1):2172\u20132182. https:\/\/doi.org\/10.1111\/ejn.12205","journal-title":"Eur J Neurosci"},{"issue":"7","key":"4706_CR26","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/brain\/awt134","volume":"136","author":"MJ Hurley","year":"2013","unstructured":"Hurley MJ, Brandon B, Gentleman SM, Dexter DT (2013) Parkinson\u2019s disease is associated with altered expression of CaV1 channels and calcium-binding proteins. Brain 136(7):2077\u20132097. https:\/\/doi.org\/10.1093\/brain\/awt134","journal-title":"Brain"},{"issue":"1","key":"4706_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/1440-1681.13587","volume":"49","author":"W Jiang","year":"2022","unstructured":"Jiang W, Zou W, Hu M et al (2022) Hydrogen sulphide attenuates neuronal apoptosis of substantia nigra by re-establishing autophagic flux via promoting leptin signalling in a 6-hydroxydopamine rat model of Parkinson\u2019s disease. Clin Exp Pharmacol Physiol 49(1):122\u2013133. https:\/\/doi.org\/10.1111\/1440-1681.13587","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4706_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fnins.2019.00457","volume":"13","author":"\u0160 Lehtonen","year":"2019","unstructured":"Lehtonen \u0160, Sonninen TM, Wojciechowski S, Goldsteins G, Koistinaho J (2019) Dysfunction of Cellular Proteostasis in Parkinson\u2019s Disease. Front Neurosci 13:457. https:\/\/doi.org\/10.3389\/fnins.2019.00457","journal-title":"Front Neurosci"},{"issue":"1","key":"4706_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10571-024-01459-4","volume":"44","author":"W Zeng","year":"2024","unstructured":"Zeng W, Cai J, Zhang L, Peng Q (2024) Iron Deposition in Parkinson\u2019s Disease: A Mini-Review. Cell Mol Neurobiol 44(1):26. https:\/\/doi.org\/10.1007\/s10571-024-01459-4","journal-title":"Cell Mol Neurobiol"},{"key":"4706_CR30","doi-asserted-by":"publisher","unstructured":"Wu, L, Liu, M, Liang, J et al (2021) Ferroptosis as a New Mechanism in Parkinson\u2019s Disease Therapy Using Traditional Chinese Medicine. Frontiers in Pharmacology 12. https:\/\/doi.org\/10.3389\/fphar.2021.659584.","DOI":"10.3389\/fphar.2021.659584"},{"key":"4706_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neubiorev.2019.06.018","volume":"103","author":"AR Dunn","year":"2019","unstructured":"Dunn AR, O\u2019Connell KMS, Kaczorowski CC (2019) Gene-by-environment interactions in Alzheimer\u2019s disease and Parkinson\u2019s disease. Neurosci Biobehav Rev 103:73\u201380. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.06.018","journal-title":"Neurosci Biobehav Rev"},{"key":"4706_CR32","doi-asserted-by":"publisher","first-page":"160851","DOI":"10.1016\/j.scitotenv.2022.160851","volume":"864","author":"S Li","year":"2023","unstructured":"Li S, Ritz B, Gong Y et al (2023) Proximity to residential and workplace pesticides application and the risk of progression of Parkinson\u2019s diseases in Central California. Sci Total Environ 864:160851. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.160851","journal-title":"Sci Total Environ"},{"issue":"1","key":"4706_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000255462","volume":"34","author":"T Fukushima","year":"2009","unstructured":"Fukushima T, Tan X, Luo Y, Kanda H (2009) Relationship between Blood Levels of Heavy Metals and Parkinson\u2019s Disease in China. Neuroepidemiology 34(1):18\u201324. https:\/\/doi.org\/10.1159\/000255462","journal-title":"Neuroepidemiology"},{"issue":"1","key":"4706_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/mds.870080116","volume":"8","author":"BA Rybicki","year":"1993","unstructured":"Rybicki BA, Johnson CC, Uman J, Gorell JM (1993) Parkinson\u2019s disease mortality and the industrial use of heavy metals in Michigan. Mov Disord 8(1):87\u201392. https:\/\/doi.org\/10.1002\/mds.870080116","journal-title":"Mov Disord"},{"issue":"20","key":"4706_CR35","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1212\/WNL.0000000000005522","volume":"90","author":"RC Gardner","year":"2018","unstructured":"Gardner RC, Byers AL, Barnes DE, Li Y, Boscardin J, Yaffe K (2018) Mild TBI and risk of parkinson disease: a chronic effects of neurotrauma consortium study. Neurology 90(20):e1771\u2013e1779. https:\/\/doi.org\/10.1212\/WNL.0000000000005522","journal-title":"Neurology"},{"issue":"4","key":"4706_CR36","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","volume":"130","author":"MC Dewan","year":"2019","unstructured":"Dewan MC, Rattani A, Gupta S et al (2019) Estimating the global incidence of traumatic brain injury. J Neurosurg JNS 130(4):1080\u20131097. https:\/\/doi.org\/10.3171\/2017.10.JNS17352","journal-title":"J Neurosurg JNS"},{"issue":"1","key":"4706_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","volume":"18","author":"SL James","year":"2019","unstructured":"James SL, Theadom A, Ellenbogen RG et al (2019) Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(1):56\u201387. https:\/\/doi.org\/10.1016\/S1474-4422(18)30415-0","journal-title":"Lancet Neurol"},{"issue":"10","key":"4706_CR38","doi-asserted-by":"publisher","first-page":"e075049","DOI":"10.1136\/bmjopen-2023-075049","volume":"13","author":"B Guan","year":"2023","unstructured":"Guan B, Anderson DB, Chen L, Feng S, Zhou H (2023) Global, regional and national burden of traumatic brain injury and spinal cord injury, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. BMJ Open 13(10):e075049. https:\/\/doi.org\/10.1136\/bmjopen-2023-075049","journal-title":"BMJ Open"},{"issue":"9","key":"4706_CR39","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1089\/neu.2006.0245","volume":"24","author":"JF Malec","year":"2007","unstructured":"Malec JF, Brown AW, Leibson CL, Flaada JT, Mandrekar JN, Diehl NN, Perkins PK (2007) The mayo classification system for traumatic brain injury severity. J Neurotrauma 24(9):1417\u20131424. https:\/\/doi.org\/10.1089\/neu.2006.0245","journal-title":"J Neurotrauma"},{"issue":"1","key":"4706_CR40","doi-asserted-by":"publisher","first-page":"e0146039","DOI":"10.1371\/journal.pone.0146039","volume":"11","author":"ME Hoffer","year":"2016","unstructured":"Hoffer ME, Szczupak M, Kiderman A et al (2016) Neurosensory symptom complexes after acute mild traumatic brain Injury. PLoS ONE 11(1):e0146039. https:\/\/doi.org\/10.1371\/journal.pone.0146039","journal-title":"PLoS ONE"},{"issue":"3","key":"4706_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12031-019-01422-9","volume":"70","author":"I Namdar","year":"2020","unstructured":"Namdar I, Feldman R, Glazer S et al (2020) Motor effects of minimal traumatic brain injury in mice. J Mol Neurosci 70(3):365\u2013377. https:\/\/doi.org\/10.1007\/s12031-019-01422-9","journal-title":"J Mol Neurosci"},{"issue":"4","key":"4706_CR42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00221-008-1324-x","volume":"187","author":"JJ Sosnoff","year":"2008","unstructured":"Sosnoff JJ, Broglio SP, Ferrara MS (2008) Cognitive and motor function are associated following mild traumatic brain injury. Exp Brain Res 187(4):563\u2013571. https:\/\/doi.org\/10.1007\/s00221-008-1324-x","journal-title":"Exp Brain Res"},{"issue":"2","key":"4706_CR43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jss.2013.03.075","volume":"184","author":"SH Yang","year":"2013","unstructured":"Yang SH, Gustafson J, Gangidine M et al (2013) A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits. J Surg Res 184(2):981\u2013988. https:\/\/doi.org\/10.1016\/j.jss.2013.03.075","journal-title":"J Surg Res"},{"issue":"7","key":"4706_CR44","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1682\/JRRD.2006.12.0158","volume":"44","author":"W Walker","year":"2007","unstructured":"Walker W, Pickett T (2007) Motor impairment after severe traumatic brain injury: A longitudinal multicenter study. J Rehabil Res Dev 44(7):975\u2013982","journal-title":"J Rehabil Res Dev"},{"issue":"4","key":"4706_CR45","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/09540260310001606728","volume":"15","author":"DJ Schretlen","year":"2003","unstructured":"Schretlen DJ, Shapiro AM (2003) A quantitative review of the effects of traumatic brain injury on cognitive functioning. Int Rev Psychiatry 15(4):341\u2013349. https:\/\/doi.org\/10.1080\/09540260310001606728","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"4706_CR46","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1089\/neu.2016.4508","volume":"34","author":"LB Tucker","year":"2016","unstructured":"Tucker LB, Burke JF, Fu AH, McCabe JT (2016) Neuropsychiatric symptom modeling in male and female C57BL\/6J mice after experimental traumatic brain Injury. J Neurotrauma 34(4):890\u2013905. https:\/\/doi.org\/10.1089\/neu.2016.4508","journal-title":"J Neurotrauma"},{"issue":"9","key":"4706_CR47","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1080\/02699052.2019.1631486","volume":"33","author":"F Lecuyer Gigu\u00e8re","year":"2019","unstructured":"Lecuyer Gigu\u00e8re F, Frasnelli A, De Guise \u00c9, Frasnelli J (2019) Olfactory, cognitive and affective dysfunction assessed 24 hours and one year after a mild Traumatic Brain Injury (mTBI). Brain Inj 33(9):1184\u20131193. https:\/\/doi.org\/10.1080\/02699052.2019.1631486","journal-title":"Brain Inj"},{"key":"4706_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clineuro.2015.11.013","volume":"140","author":"J Frasnelli","year":"2016","unstructured":"Frasnelli J, Lagu\u00eb-Beauvais M, LeBlanc J et al (2016) Olfactory function in acute traumatic brain injury. Clin Neurol Neurosurg 140:68\u201372. https:\/\/doi.org\/10.1016\/j.clineuro.2015.11.013","journal-title":"Clin Neurol Neurosurg"},{"key":"4706_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbr.2019.02.045","volume":"365","author":"A Arulsamy","year":"2019","unstructured":"Arulsamy A, Corrigan F, Collins-Praino LE (2019) Cognitive and neuropsychiatric impairments vary as a function of injury severity at 12 months post-experimental diffuse traumatic brain injury: Implications for dementia development. Behav Brain Res 365:66\u201376. https:\/\/doi.org\/10.1016\/j.bbr.2019.02.045","journal-title":"Behav Brain Res"},{"key":"4706_CR50","doi-asserted-by":"publisher","first-page":"1180353","DOI":"10.3389\/fneur.2023.1180353","volume":"14","author":"F Corrigan","year":"2023","unstructured":"Corrigan F, Wee IC, Collins-Praino LE (2023) Chronic motor performance following different traumatic brain injury severity-A systematic review. Front Neurol 14:1180353. https:\/\/doi.org\/10.3389\/fneur.2023.1180353","journal-title":"Front Neurol"},{"issue":"5","key":"4706_CR51","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/02699052.2018.1432074","volume":"32","author":"A Ciofalo","year":"2018","unstructured":"Ciofalo A, De Vincentiis M, Iannella G et al (2018) Mild traumatic brain injury: evaluation of olfactory dysfunction and clinical\u2013neurological characteristics. Brain Inj 32(5):550\u2013556. https:\/\/doi.org\/10.1080\/02699052.2018.1432074","journal-title":"Brain Inj"},{"issue":"5","key":"4706_CR52","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.sleep.2007.04.014","volume":"9","author":"S Schreiber","year":"2008","unstructured":"Schreiber S, Barkai G, Gur-Hartman T, Peles E, Tov N, Dolberg OT, Pick CG (2008) Long-lasting sleep patterns of adult patients with minor traumatic brain injury (mTBI) and non-mTBI subjects. Sleep Med 9(5):481\u2013487. https:\/\/doi.org\/10.1016\/j.sleep.2007.04.014","journal-title":"Sleep Med"},{"issue":"1","key":"4706_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/neu.2000.17.83","volume":"17","author":"JA Cheney","year":"2000","unstructured":"Cheney JA, Brown AL, Bareyre FM et al (2000) The Novel Compound LOE 908 Attenuates Acute Neuromotor Dysfunction but Not Cognitive Impairment or Cortical Tissue Loss Following Traumatic Brain Injury in Rats. J Neurotrauma 17(1):83\u201391. https:\/\/doi.org\/10.1089\/neu.2000.17.83","journal-title":"J Neurotrauma"},{"key":"4706_CR54","doi-asserted-by":"publisher","first-page":"113222","DOI":"10.1016\/j.expneurol.2020.113222","volume":"327","author":"V Aida","year":"2020","unstructured":"Aida V, Niedzielko TL, Szaflarski JP, Floyd CL (2020) Acute administration of perampanel, an AMPA receptor antagonist, reduces cognitive impairments after traumatic brain injury in rats. Exp Neurol 327:113222. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113222","journal-title":"Exp Neurol"},{"issue":"5","key":"4706_CR55","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1037\/a0029239","volume":"26","author":"G Spitz","year":"2012","unstructured":"Spitz G, Ponsford JL (2012) Association Between Cognitive Performance and Functional Outcome Following Traumatic Brain Injury: A Longitudianl Multilevel Examination. Neuropsychology 26(5):604\u2013612. https:\/\/doi.org\/10.1037\/a0029239","journal-title":"Neuropsychology"},{"issue":"5","key":"4706_CR56","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2340\/16501977-2084","volume":"48","author":"F Khan","year":"2016","unstructured":"Khan F, Amatya B, Judson R, Chung P, Truesdale M, Elmalik A, Galea MP (2016) Factors associated with long-term functional and psychological outcomes in persons with moderate to severe traumatic brain injury. J Rehabil Med 48(5):442\u2013448. https:\/\/doi.org\/10.2340\/16501977-2084","journal-title":"J Rehabil Med"},{"issue":"8","key":"4706_CR57","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/02699052.2018.1469043","volume":"32","author":"M Bratt","year":"2018","unstructured":"Bratt M, Skandsen T, Hummel T, Moen KG, Vik A, Nordg\u00e5rd S, Helvik A-S (2018) Frequency and prognostic factors of olfactory dysfunction after traumatic brain injury. Brain Inj 32(8):1021\u20131027. https:\/\/doi.org\/10.1080\/02699052.2018.1469043","journal-title":"Brain Inj"},{"issue":"11","key":"4706_CR58","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.2174\/1570159x19666210215123914","volume":"19","author":"N Khatri","year":"2021","unstructured":"Khatri N, Sumadhura B, Kumar S, Kaundal RK, Sharma S, Datusalia AK (2021) The Complexity of Secondary Cascade Consequent to Traumatic Brain Injury: Pathobiology and Potential Treatments. Curr Neuropharmacol 19(11):1984\u20132011. https:\/\/doi.org\/10.2174\/1570159x19666210215123914","journal-title":"Curr Neuropharmacol"},{"issue":"16","key":"4706_CR59","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1002\/jnr.22510","volume":"88","author":"RD Readnower","year":"2010","unstructured":"Readnower RD, Chavko M, Adeeb S, Conroy MD, Pauly JR, McCarron RM, Sullivan PG (2010) Increase in blood\u2013brain barrier permeability, oxidative stress, and activated microglia in a rat model of blast-induced traumatic brain injury. J Neurosci Res 88(16):3530\u20133539. https:\/\/doi.org\/10.1002\/jnr.22510","journal-title":"J Neurosci Res"},{"issue":"5","key":"4706_CR60","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1046\/j.1471-4159.2000.0752178.x","volume":"75","author":"VA Tyurin","year":"2000","unstructured":"Tyurin VA, Tyurina YY, Borisenko GG et al (2000) Oxidative stress following traumatic brain injury in rats. J Neurochem 75(5):2178\u20132189. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0752178.x","journal-title":"J Neurochem"},{"issue":"6","key":"4706_CR61","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1471-4159.1993.tb07437.x","volume":"61","author":"AM Palmer","year":"1993","unstructured":"Palmer AM, Marion DW, Botscheller ML, Swedlow PE, Styren SD, DeKosky ST (1993) Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem 61(6):2015\u20132024. https:\/\/doi.org\/10.1111\/j.1471-4159.1993.tb07437.x","journal-title":"J Neurochem"},{"issue":"8","key":"4706_CR62","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1089\/neu.2008.0857","volume":"26","author":"LK Gilmer","year":"2009","unstructured":"Gilmer LK, Roberts KN, Joy K, Sullivan PG, Scheff SW (2009) Early mitochondrial dysfunction after cortical contusion injury. J Neurotrauma 26(8):1271\u20131280. https:\/\/doi.org\/10.1089\/neu.2008.0857","journal-title":"J Neurotrauma"},{"issue":"4","key":"4706_CR63","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s10237-021-01453-5","volume":"20","author":"A Kant","year":"2021","unstructured":"Kant A, Medhekar NV, Bhandakkar TK (2021) Spatial calcium kinetics after a traumatic brain injury. Biomech Model Mechanobiol 20(4):1413\u20131430. https:\/\/doi.org\/10.1007\/s10237-021-01453-5","journal-title":"Biomech Model Mechanobiol"},{"key":"4706_CR64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2023.02.001","volume":"198","author":"JD Pandya","year":"2023","unstructured":"Pandya JD, Musyaju S, Modi HR et al (2023) Comprehensive evaluation of mitochondrial redox profile, calcium dynamics, membrane integrity and apoptosis markers in a preclinical model of severe penetrating traumatic brain injury. Free Radical Biol Med 198:44\u201358. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.02.001","journal-title":"Free Radical Biol Med"},{"issue":"10","key":"4706_CR65","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3174\/ajnr.A2637","volume":"32","author":"E Raz","year":"2011","unstructured":"Raz E, Jensen JH, Ge Y et al (2011) Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study. Am J Neuroradiol 32(10):1851. https:\/\/doi.org\/10.3174\/ajnr.A2637","journal-title":"Am J Neuroradiol"},{"key":"4706_CR66","doi-asserted-by":"publisher","unstructured":"Barker, S, Paul, BD, and Pieper, AA Increased risk of aging-related neurodegenerative disease after traumatic brain injury. biomedicines, 2023. 11. https:\/\/doi.org\/10.3390\/biomedicines11041154","DOI":"10.3390\/biomedicines11041154"},{"issue":"1","key":"4706_CR67","doi-asserted-by":"publisher","first-page":"e53376","DOI":"10.1371\/journal.pone.0053376","volume":"8","author":"SA Acosta","year":"2013","unstructured":"Acosta SA, Tajiri N, Shinozuka K et al (2013) Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS ONE 8(1):e53376\u2013e53376. https:\/\/doi.org\/10.1371\/journal.pone.0053376","journal-title":"PLoS ONE"},{"issue":"3","key":"4706_CR68","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/brain\/awx357","volume":"141","author":"PO Jenkins","year":"2018","unstructured":"Jenkins PO, De Simoni S, Bourke NJ et al (2018) Dopaminergic abnormalities following traumatic brain injury. Brain 141(3):797\u2013810. https:\/\/doi.org\/10.1093\/brain\/awx357","journal-title":"Brain"},{"issue":"9","key":"4706_CR69","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1089\/neu.2010.1723","volume":"28","author":"CB Hutson","year":"2011","unstructured":"Hutson CB, Lazo CR, Mortazavi F, Giza CC, Hovda D, Chesselet M-F (2011) Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat. J Neurotrauma 28(9):1783\u20131801. https:\/\/doi.org\/10.1089\/neu.2010.1723","journal-title":"J Neurotrauma"},{"issue":"2","key":"4706_CR70","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1471-4159.2005.03382.x","volume":"95","author":"AK Wagner","year":"2005","unstructured":"Wagner AK, Sokoloski JE, Ren D et al (2005) Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J Neurochem 95(2):457\u2013465. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03382.x","journal-title":"J Neurochem"},{"issue":"2","key":"4706_CR71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.expneurol.2007.06.018","volume":"208","author":"K Uryu","year":"2007","unstructured":"Uryu K, Chen X-H, Martinez D et al (2007) Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol 208(2):185\u2013192. https:\/\/doi.org\/10.1016\/j.expneurol.2007.06.018","journal-title":"Exp Neurol"},{"key":"4706_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04035-5","author":"N Panayi","year":"2024","unstructured":"Panayi N, Schulz P, He P, Hanna B, Lifshitz J, Rowe RK, Sierks MR (2024) Traumatic brain injury in mice generates early-stage alzheimer\u2019s disease related protein pathology that correlates with neurobehavioral deficits. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04035-5","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4706_CR73","doi-asserted-by":"publisher","first-page":"a008862","DOI":"10.1101\/cshperspect.a008862","volume":"1","author":"CG Goetz","year":"2011","unstructured":"Goetz CG (2011) The history of Parkinson\u2019s disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med 1(1):a008862\u2013a008862. https:\/\/doi.org\/10.1101\/cshperspect.a008862","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"4706_CR74","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6\/3c742::AID-AJMG29\/3e3.0.CO;2-\/","volume":"88","author":"CA Taylor","year":"1999","unstructured":"Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH (1999) Environmental, medical, and family history risk factors for Parkinson\u2019s disease: A New England-based case control study. Am J Med Genet 88(6):742\u2013749. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19991215)88:6\/3c742::AID-AJMG29\/3e3.0.CO;2-\/","journal-title":"Am J Med Genet"},{"issue":"1","key":"4706_CR75","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ana.20882","volume":"60","author":"SM Goldman","year":"2006","unstructured":"Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW (2006) Head injury and Parkinson\u2019s disease risk in twins. Ann Neurol 60(1):65\u201372. https:\/\/doi.org\/10.1002\/ana.20882","journal-title":"Ann Neurol"},{"issue":"10","key":"4706_CR76","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/oem.2006.027003","volume":"64","author":"FD Dick","year":"2007","unstructured":"Dick FD, Palma GD, Ahmadi A et al (2007) Environmental risk factors for Parkinson\u2019s disease and parkinsonism: the Geoparkinson study. Occup Environ Med 64(10):666. https:\/\/doi.org\/10.1136\/oem.2006.027003","journal-title":"Occup Environ Med"},{"issue":"1","key":"4706_CR77","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.22499","volume":"71","author":"SM Goldman","year":"2012","unstructured":"Goldman SM, Kamel F, Ross GW et al (2012) Head injury, alpha-synuclein Rep1, and Parkinson\u2019s disease. Ann Neurol 71(1):40\u201348. https:\/\/doi.org\/10.1002\/ana.22499","journal-title":"Ann Neurol"},{"issue":"2","key":"4706_CR78","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0022-510X(95)00148-U","volume":"132","author":"CN Martyn","year":"1995","unstructured":"Martyn CN, Osmond C (1995) Parkinson\u2019s disease and the environment in early life. J Neurol Sci 132(2):201\u2013206. https:\/\/doi.org\/10.1016\/0022-510X(95)00148-U","journal-title":"J Neurol Sci"},{"issue":"6","key":"4706_CR79","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/1531-8257(199911)14:6<928::AID-MDS1004>3.0.CO;2-Z","volume":"14","author":"A-M Kuopio","year":"1999","unstructured":"Kuopio A-M, Marttila RJ, Helenius H, Rinne UK (1999) Environmental risk factors in Parkinson\u2019s disease. Mov Disord 14(6):928\u2013939. https:\/\/doi.org\/10.1002\/1531-8257(199911)14:6%3c928::AID-MDS1004%3e3.0.CO;2-Z","journal-title":"Mov Disord"},{"issue":"4","key":"4706_CR80","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1034\/j.1600-0404.2003.00128.x","volume":"108","author":"M Baldereschi","year":"2003","unstructured":"Baldereschi M, Di Carlo A, Vanni P et al (2003) Lifestyle-related risk factors for Parkinson\u2019s disease: a population-based study. Acta Neurol Scand 108(4):239\u2013244. https:\/\/doi.org\/10.1034\/j.1600-0404.2003.00128.x","journal-title":"Acta Neurol Scand"},{"issue":"4\u20135","key":"4706_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/10408363.2013.844678","volume":"50","author":"JC Wong","year":"2013","unstructured":"Wong JC, Hazrati L-N (2013) Parkinson\u2019s disease, parkinsonism, and traumatic brain injury. Crit Rev Clin Lab Sci 50(4\u20135):103\u2013106. https:\/\/doi.org\/10.3109\/10408363.2013.844678","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"9","key":"4706_CR82","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/mds.25458","volume":"28","author":"S Jafari","year":"2013","unstructured":"Jafari S, Etminan M, Aminzadeh F, Samii A (2013) Head injury and risk of Parkinson disease: A systematic review and meta-analysis. Mov Disord 28(9):1222\u20131229. https:\/\/doi.org\/10.1002\/mds.25458","journal-title":"Mov Disord"},{"issue":"4","key":"4706_CR83","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s13760-023-02209-x","volume":"123","author":"M Balabandian","year":"2023","unstructured":"Balabandian M, Noori M, Lak B, Karimizadeh Z, Nabizadeh F (2023) Traumatic brain injury and risk of Parkinson\u2019s disease: a meta-analysis. Acta Neurol Belg 123(4):1225\u20131239. https:\/\/doi.org\/10.1007\/s13760-023-02209-x","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"4706_CR84","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/00207454.2016.1239196","volume":"127","author":"K Rumalla","year":"2017","unstructured":"Rumalla K, Gondi KT, Reddy AY, Mittal MK (2017) Association of Parkinson\u2019s disease with hospitalization for traumatic brain injury. Int J Neurosci 127(4):326\u2013333. https:\/\/doi.org\/10.1080\/00207454.2016.1239196","journal-title":"Int J Neurosci"},{"issue":"2","key":"4706_CR85","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3171\/2015.2.JNS14503","volume":"124","author":"DC Perry","year":"2016","unstructured":"Perry DC, Sturm VE, Peterson MJ et al (2016) Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis. J Neurosurg 124(2):511\u2013526. https:\/\/doi.org\/10.3171\/2015.2.JNS14503","journal-title":"J Neurosurg"},{"issue":"4","key":"4706_CR86","first-page":"435","volume":"21","author":"A Priyadarshi","year":"2000","unstructured":"Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S (2000) A meta-analysis of Parkinson\u2019s disease and exposure to pesticides. Neurotoxicology 21(4):435\u2013440","journal-title":"Neurotoxicology"},{"key":"4706_CR87","doi-asserted-by":"publisher","first-page":"a2494","DOI":"10.1136\/bmj.a2494","volume":"337","author":"R Kathrine","year":"2008","unstructured":"Kathrine R, Beate R, Lise K, Nick M, J\u00f8rgen HO (2008) Risk of Parkinson\u2019s disease after hospital contact for head injury: population based case-control study. BMJ 337:a2494. https:\/\/doi.org\/10.1136\/bmj.a2494","journal-title":"BMJ"},{"key":"4706_CR88","doi-asserted-by":"publisher","first-page":"906274","DOI":"10.1155\/2013\/906274","volume":"2013","author":"NE Allen","year":"2013","unstructured":"Allen NE, Schwarzel AK, Canning CG (2013) Recurrent Falls in Parkinson\u2019s Disease: A Systematic Review. Parkinson\u2019s Disease 2013:906274. https:\/\/doi.org\/10.1155\/2013\/906274","journal-title":"Parkinson\u2019s Disease"},{"issue":"5","key":"4706_CR89","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ana.25074","volume":"82","author":"A Camacho-Soto","year":"2017","unstructured":"Camacho-Soto A, Warden MN, Searles Nielsen S, Salter A, Brody DL, Prather H, Racette BA (2017) Traumatic brain injury in the prodromal period of Parkinson\u2019s disease: A large epidemiological study using medicare data. Ann Neurol 82(5):744\u2013754. https:\/\/doi.org\/10.1002\/ana.25074","journal-title":"Ann Neurol"},{"issue":"9","key":"4706_CR90","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","volume":"73","author":"PK Crane","year":"2016","unstructured":"Crane PK, Gibbons LE, Dams-O\u2019Connor K et al (2016) Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings. JAMA Neurol 73(9):1062\u20131069. https:\/\/doi.org\/10.1001\/jamaneurol.2016.1948","journal-title":"JAMA Neurol"},{"issue":"6","key":"4706_CR91","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ana.24396","volume":"77","author":"RC Gardner","year":"2015","unstructured":"Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K (2015) Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol 77(6):987\u2013995. https:\/\/doi.org\/10.1002\/ana.24396","journal-title":"Ann Neurol"},{"key":"4706_CR92","doi-asserted-by":"publisher","unstructured":"Stachnik, C and Barton, B (2015) The Effects of Comorbid Traumatic Brain Injury on Motor and Non-Motor Symptoms of Parkinson\u2019s Disease (P3.025). Neurology 84(14_supplement): P3.025.https:\/\/doi.org\/10.1212\/WNL.84.14_supplement.P3.025.","DOI":"10.1212\/WNL.84.14_supplement.P3.025"},{"key":"4706_CR93","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.05.024","volume":"30","author":"DM Schiehser","year":"2016","unstructured":"Schiehser DM, Filoteo JV, Litvan I, Pirogovsky-Turk E, Lessig SL, Song DS (2016) Cognitive functioning in individuals with Parkinson\u2019s disease and traumatic brain injury: A longitudinal study. Parkinsonism Relat Disord 30:58\u201361. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.05.024","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"4706_CR94","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/09540261.2019.1656177","volume":"32","author":"JM Joyce","year":"2020","unstructured":"Joyce JM, Monchi O, Ismail Z et al (2020) The impact of traumatic brain injury on cognitive and neuropsychiatric symptoms of Parkinson\u2019s disease. Int Rev Psychiatry (Abingdon, England) 32(1):46\u201360. https:\/\/doi.org\/10.1080\/09540261.2019.1656177","journal-title":"Int Rev Psychiatry (Abingdon, England)"},{"key":"4706_CR95","doi-asserted-by":"publisher","unstructured":"Agtarap, S, Campbell-Sills, L, Thomas, ML, Kessler, RC, Ursano, RJ, and Stein, MB (2019) ostconcussive, Posttraumatic Stress and Depressive Symptoms in Recently Deployed U.S. Army Soldiers With Traumatic Brain Injury. Psychological Assessment 31(11): 1340\u20131356. https:\/\/doi.org\/10.1037\/pas0000756.","DOI":"10.1037\/pas0000756"},{"key":"4706_CR96","doi-asserted-by":"crossref","unstructured":"Wojcik, BE, Stein, CR, Bagg, K, Humphrey, RJ, and Orosco, J (2010) Traumatic brain injury hospitalizations of U.S. army soldiers deployed to Afghanistan and Iraq. American Journal of Preventative Medicine 38(1): S108-S116.","DOI":"10.1016\/j.amepre.2009.10.006"},{"issue":"1","key":"4706_CR97","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41398-023-02569-1","volume":"13","author":"SY Kim","year":"2023","unstructured":"Kim SY, Yeh P-H, Ollinger JM, Morris HD, Hood MN, Ho VB, Choi KH (2023) Military-related mild traumatic brain injury: clinical characteristics, advanced neuroimaging, and molecular mechanisms. Transl Psychiatry 13(1):289. https:\/\/doi.org\/10.1038\/s41398-023-02569-1","journal-title":"Transl Psychiatry"},{"issue":"9","key":"4706_CR98","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/gerona\/glw341","volume":"72","author":"RC Gardner","year":"2017","unstructured":"Gardner RC, Peltz CB, Kenney K, Covinsky KE, Diaz-Arrastia R, Yaffe K (2017) Remote traumatic brain injury is associated with motor dysfunction in older military veterans. J Gerontol A Biol Sci Med Sci 72(9):1233\u20131238. https:\/\/doi.org\/10.1093\/gerona\/glw341","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"4706_CR99","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/mds.29457","volume":"38","author":"GD Scott","year":"2023","unstructured":"Scott GD, Neilson LE, Woltjer R, Quinn JF, Lim MM (2023) Lifelong association of disorders related to military trauma with subsequent parkinson\u2019s disease. Mov Disord 38(8):1483\u20131492. https:\/\/doi.org\/10.1002\/mds.29457","journal-title":"Mov Disord"},{"issue":"1","key":"4706_CR100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ana.25726","volume":"88","author":"DL White","year":"2020","unstructured":"White DL, Kunik ME, Yu H et al (2020) Post-traumatic stress disorder is associated with further increased parkinson\u2019s disease risk in veterans with traumatic brain injury. Ann Neurol 88(1):33\u201341. https:\/\/doi.org\/10.1002\/ana.25726","journal-title":"Ann Neurol"},{"key":"4706_CR101","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.janxdis.2015.02.003","volume":"31","author":"JJ Fulton","year":"2015","unstructured":"Fulton JJ, Calhoun PS, Wagner HR et al (2015) The prevalence of posttraumatic stress disorder in Operation Enduring Freedom\/Operation Iraqi Freedom (OEF\/OIF) Veterans: A meta-analysis. J Anxiety Disord 31:98\u2013107","journal-title":"J Anxiety Disord"},{"issue":"6","key":"4706_CR102","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00132985-200506000-00018","volume":"5","author":"C Laino","year":"2005","unstructured":"Laino C (2005) Military Deployment May Raise Risk of Parkinson\u2019s Disease. Neurol Today 5(6):48","journal-title":"Neurol Today"},{"key":"4706_CR103","doi-asserted-by":"publisher","unstructured":"Fearnley, JM and Lees, AJ (1991) Ageing and Parkinson's disease : substantia nigra regional selectivity. Brain (London, England : 1878) 114(5): 2283\u20132301.https:\/\/doi.org\/10.1093\/brain\/114.5.2283.","DOI":"10.1093\/brain\/114.5.2283"},{"issue":"8","key":"4706_CR104","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB et al (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136(8):2419\u20132431. https:\/\/doi.org\/10.1093\/brain\/awt192","journal-title":"Brain"},{"issue":"6","key":"4706_CR105","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"H-C Cheng","year":"2010","unstructured":"Cheng H-C, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67(6):715\u2013725. https:\/\/doi.org\/10.1002\/ana.21995","journal-title":"Ann Neurol"},{"issue":"14","key":"4706_CR106","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/nejm198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson\u2019s Disease. N Engl J Med 318(14):876\u2013880. https:\/\/doi.org\/10.1056\/nejm198804073181402","journal-title":"N Engl J Med"},{"key":"4706_CR107","doi-asserted-by":"publisher","unstructured":"Ma, Y, Dhawan, V, Mentis, M, Chaly, T, Spetsieris, PG, and Eidelberg, D (2002) Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study. Synapse (New York, N.Y.) 45(2): 125\u2013133.https:\/\/doi.org\/10.1002\/syn.10090.","DOI":"10.1002\/syn.10090"},{"issue":"6","key":"4706_CR108","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25103","volume":"82","author":"V Kaasinen","year":"2017","unstructured":"Kaasinen V, Vahlberg T (2017) Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies. Ann Neurol 82(6):873\u2013882. https:\/\/doi.org\/10.1002\/ana.25103","journal-title":"Ann Neurol"},{"issue":"8","key":"4706_CR109","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/jcbfm.2014.87","volume":"34","author":"AK Wagner","year":"2014","unstructured":"Wagner AK, Scanion JM, Becker CR et al (2014) The influence of genetic variants on striatal dopamine transporter and D2 Receptor Binding after TB. J Cereb Blood Flow Metab 34(8):1328\u20131339. https:\/\/doi.org\/10.1038\/jcbfm.2014.87","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"4706_CR110","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s002590000308","volume":"27","author":"E Donnemiller","year":"2000","unstructured":"Donnemiller E, Brenneis C, Wissel J, Scherfler C, Poewe W, Riccabona G, Wenning GK (2000) Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPET study using 123I-\u03b2-CIT and 123I-IBZM. Eur J Nucl Med 27(9):1410\u20131414. https:\/\/doi.org\/10.1007\/s002590000308","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"4706_CR111","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/jnnp-2019-321759","volume":"91","author":"PO Jenkins","year":"2020","unstructured":"Jenkins PO, Roussakis A-A, De Simoni S et al (2020) Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 91(6):631\u2013637. https:\/\/doi.org\/10.1136\/jnnp-2019-321759","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"4706_CR112","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/mds.28632","volume":"36","author":"V Kaasinen","year":"2021","unstructured":"Kaasinen V, Vahlberg T, Stoessl AJ, Strafella AP, Antonini A (2021) Dopamine receptors in parkinson\u2019s disease: a meta-analysis of imaging studies. Mov Disord 36(8):1781\u20131791. https:\/\/doi.org\/10.1002\/mds.28632","journal-title":"Mov Disord"},{"issue":"1","key":"4706_CR113","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.expneurol.2011.12.003","volume":"234","author":"DR van Bregt","year":"2012","unstructured":"van Bregt DR, Thomas TC, Hinzman JM et al (2012) Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat. Exp Neurol 234(1):8\u201319. https:\/\/doi.org\/10.1016\/j.expneurol.2011.12.003","journal-title":"Exp Neurol"},{"issue":"5","key":"4706_CR114","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/jcp.24830","volume":"230","author":"SA Acosta","year":"2015","unstructured":"Acosta SA, Tajiri N, de la Pena I, Bastawrous M, Sanberg PR, Kaneko Y, Borlongan CV (2015) Alpha-synuclein as a pathological link between chronic traumatic brain injury and parkinson\u2019s disease. J Cell Physiol 230(5):1024\u20131032. https:\/\/doi.org\/10.1002\/jcp.24830","journal-title":"J Cell Physiol"},{"key":"4706_CR115","doi-asserted-by":"crossref","unstructured":"Wee, IC, Arulsamy, A, Corrigan, F, and Collins-Praino, L Long-Term Impact of Diffuse Traumatic Brain Injury on Neuroinflammation and Catecholaminergic Signaling: Potential Relevance for Parkinson\u2019s Disease Risk. Molecules, 2024. 29, DOI|.","DOI":"10.3390\/molecules29071470"},{"issue":"4","key":"4706_CR116","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1046\/j.1471-4159.1995.64041669.x","volume":"64","author":"V Blanchard","year":"1995","unstructured":"Blanchard V, Chritin M, Vyas S et al (1995) Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J Neurochem 64(4):1669\u20131679. https:\/\/doi.org\/10.1046\/j.1471-4159.1995.64041669.x","journal-title":"J Neurochem"},{"issue":"1","key":"4706_CR117","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neulet.2004.09.026","volume":"372","author":"JL Massucci","year":"2004","unstructured":"Massucci JL, Kline AE, Ma X, Zafonte RD, Dixon CE (2004) Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci Lett 372(1):127\u2013131. https:\/\/doi.org\/10.1016\/j.neulet.2004.09.026","journal-title":"Neurosci Lett"},{"key":"4706_CR118","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mcn.2019.06.004","volume":"98","author":"G Acosta","year":"2019","unstructured":"Acosta G, Race N, Herr S, Fernandez J, Tang J, Rogers E, Shi R (2019) Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration. Mol Cell Neurosci 98:140\u2013154. https:\/\/doi.org\/10.1016\/j.mcn.2019.06.004","journal-title":"Mol Cell Neurosci"},{"issue":"15","key":"4706_CR119","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1097\/00001756-200210280-00013","volume":"13","author":"HQ Yan","year":"2002","unstructured":"Yan HQ, Kline AE, Ma X, Li Y, Dixon CE (2002) Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. NeuroReport 13(15):1899\u20131901","journal-title":"NeuroReport"},{"key":"4706_CR120","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fnins.2016.00458","volume":"10","author":"D Impellizzeri","year":"2016","unstructured":"Impellizzeri D, Campolo M, Bruschetta G et al (2016) Traumatic brain injury leads to development of parkinson\u2019s disease related pathology in mice. Front Neurosci 10:458\u2013458. https:\/\/doi.org\/10.3389\/fnins.2016.00458","journal-title":"Front Neurosci"},{"key":"4706_CR121","doi-asserted-by":"publisher","unstructured":"Paredes-Rodriguez, E, Vegas-Suarez, S, Morera-Herreras, T, De Deurwaerdere, P, and Miguelez, C (2020) The Noradrenergic System in Parkinson\u2019s Disease. Frontiers in Pharmacology 11.https:\/\/doi.org\/10.3389\/fphar.2020.00435.","DOI":"10.3389\/fphar.2020.00435"},{"issue":"9","key":"4706_CR122","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1093\/brain\/awab236","volume":"144","author":"CEJ Doppler","year":"2021","unstructured":"Doppler CEJ, Kinnerup MB, Brune C et al (2021) Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson\u2019s disease. Brain 144(9):2732\u20132744. https:\/\/doi.org\/10.1093\/brain\/awab236","journal-title":"Brain"},{"key":"4706_CR123","doi-asserted-by":"crossref","unstructured":"Criaud M, Laurencin C, Poisson A et al (2022) Noradrenaline and movement initiation disorders in Parkinson's disease: a pharmacological functional MRI study with clonidine. Cells 11:NA","DOI":"10.3390\/cells11172640"},{"issue":"12","key":"4706_CR124","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1001\/archneur.63.12.1724","volume":"63","author":"J Tong","year":"2006","unstructured":"Tong J, Hornykiewicz O, Kish SJ (2006) Inverse relationship between brain noradrenaline level and dopamine loss in parkinson disease: a possible neuroprotective role for noradrenaline. Arch Neurol 63(12):1724\u20131728. https:\/\/doi.org\/10.1001\/archneur.63.12.1724","journal-title":"Arch Neurol"},{"issue":"6","key":"4706_CR125","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mds.27411","volume":"33","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer M, Hansen AK, Parbo P et al (2018) Decreased noradrenaline transporter density in the motor cortex of Parkinson\u2019s disease patients. Mov Disord 33(6):1006\u20131010. https:\/\/doi.org\/10.1002\/mds.27411","journal-title":"Mov Disord"},{"key":"4706_CR126","doi-asserted-by":"publisher","unstructured":"Jones, BE, Halaris, AE, McIlhany, M, and Moore, RY (1977) Ascending projections of the locus coeruleus in the rat. I. axonal transport in central noradrenaline neurons. Brain Research 127(1): 1\u201321.https:\/\/doi.org\/10.1016\/0006-8993(77)90377-8.","DOI":"10.1016\/0006-8993(77)90377-8"},{"issue":"1","key":"4706_CR127","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0006-8993(77)90378-X","volume":"127","author":"BE Jones","year":"1977","unstructured":"Jones BE, Moore RY (1977) Ascending projections of the locus coeruleus in the rat. II Autoradiographic Stud Brain Res 127(1):23\u201353. https:\/\/doi.org\/10.1016\/0006-8993(77)90378-X","journal-title":"II Autoradiographic Stud Brain Res"},{"issue":"7","key":"4706_CR128","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/ene.13628","volume":"25","author":"J Wang","year":"2018","unstructured":"Wang J, Li Y, Huang Z et al (2018) Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson\u2019s disease and its phenotypes. Eur J Neurol 25(7):949-e73. https:\/\/doi.org\/10.1111\/ene.13628","journal-title":"Eur J Neurol"},{"issue":"3","key":"4706_CR129","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1148\/radiol.2016160662","volume":"283","author":"ST Schwarz","year":"2016","unstructured":"Schwarz ST, Xing Y, Tomar P, Bajaj N, Auer DP (2016) In Vivo assessment of brainstem depigmentation in parkinson disease: potential as a severity marker for multicenter studies. Radiology 283(3):789\u2013798. https:\/\/doi.org\/10.1148\/radiol.2016160662","journal-title":"Radiology"},{"issue":"2","key":"4706_CR130","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/brain\/awx348","volume":"141","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer M, Fedorova TD, Hansen AK et al (2018) Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study. Brain 141(2):496\u2013504. https:\/\/doi.org\/10.1093\/brain\/awx348","journal-title":"Brain"},{"issue":"9","key":"4706_CR131","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/brain\/aww128","volume":"139","author":"PO Jenkins","year":"2016","unstructured":"Jenkins PO, Mehta MA, Sharp DJ (2016) Catecholamines and cognition after traumatic brain injury. Brain 139(9):2345\u20132371. https:\/\/doi.org\/10.1093\/brain\/aww128","journal-title":"Brain"},{"issue":"4","key":"4706_CR132","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrneurol.2013.29","volume":"9","author":"DH Smith","year":"2013","unstructured":"Smith DH, Johnson VE, Stewart W (2013) Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol 9(4):211\u2013221. https:\/\/doi.org\/10.1038\/nrneurol.2013.29","journal-title":"Nat Rev Neurol"},{"issue":"03","key":"4706_CR133","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-0042-1757217","volume":"17","author":"A Singh","year":"2022","unstructured":"Singh A, Prajapati HP, Kumar R, Singh NP, Kumar A (2022) Prognostic role of catecholamine in moderate-to-severe traumatic brain injury: a prospective observational cohort study. Asian J Neurosurg 17(03):435\u2013441. https:\/\/doi.org\/10.1055\/s-0042-1757217","journal-title":"Asian J Neurosurg"},{"issue":"1","key":"4706_CR134","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13054-017-1620-6","volume":"21","author":"SB Rizoli","year":"2017","unstructured":"Rizoli SB, Jaja BNR, Di Battista AP et al (2017) Catecholamines as outcome markers in isolated traumatic brain injury: the COMA-TBI study. Crit Care 21(1):37. https:\/\/doi.org\/10.1186\/s13054-017-1620-6","journal-title":"Crit Care"},{"issue":"10","key":"4706_CR135","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.injury.2020.07.054","volume":"51","author":"P Lloyd-Donald","year":"2020","unstructured":"Lloyd-Donald P, Spencer W, Cheng J, Romero L, Jithoo R, Udy A, Fitzgerald MC (2020) In adult patients with severe traumatic brain injury, does the use of norepinephrine for augmenting cerebral perfusion pressure improve neurological outcome? Systemat Rev Injury 51(10):2129\u20132134. https:\/\/doi.org\/10.1016\/j.injury.2020.07.054","journal-title":"Systemat Rev Injury"},{"issue":"1","key":"4706_CR136","doi-asserted-by":"publisher","first-page":"e000307","DOI":"10.1136\/tsaco-2019-000307","volume":"4","author":"TJ Schroeppel","year":"2019","unstructured":"Schroeppel TJ, Sharpe JP, Shahan CP et al (2019) Beta-adrenergic blockade for attenuation of catecholamine surge after traumatic brain injury: a randomized pilot trial. Trauma Surg Acute Care Open 4(1):e000307. https:\/\/doi.org\/10.1136\/tsaco-2019-000307","journal-title":"Trauma Surg Acute Care Open"},{"issue":"1","key":"4706_CR137","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/01.ccm.0000907868.50366.22","volume":"51","author":"A Alshaya","year":"2023","unstructured":"Alshaya A, Al Sulaiman K, Aldhaeefi M et al (2023) 535: Clonidine safety and efficacy in the management of catecholamine surge post-traumatic brain injury. Crit Care Med 51(1):255\u2013255. https:\/\/doi.org\/10.1097\/01.ccm.0000907868.50366.22","journal-title":"Crit Care Med"},{"key":"4706_CR138","doi-asserted-by":"publisher","unstructured":"Ding, H, Liao, L, Zheng, X et al (2021) \u03b2-Blockers for traumatic brain injury: A systematic review and meta-analysis. Journal of Trauma and Acute Care Surgery 90(6). https:\/\/doi.org\/10.1097\/TA.0000000000003094","DOI":"10.1097\/TA.0000000000003094"},{"issue":"9","key":"4706_CR139","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0003-9993(03)00148-5","volume":"84","author":"R Aquilani","year":"2003","unstructured":"Aquilani R, Iadarola P, Boschi F, Pistarini C, Arcidiaco P, Contardi A (2003) Reduced plasma levels of tyrosine, precursor of brain catecholamines, and of essential amino acids in patients with severe traumatic brain injury after rehabilitation. Arch Phys Med Rehabil 84(9):1258\u20131265. https:\/\/doi.org\/10.1016\/S0003-9993(03)00148-5","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"4706_CR140","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0006-8993(95)00032-L","volume":"674","author":"BE Levin","year":"1995","unstructured":"Levin BE, Brown KL, Pawar G, Dunn-Meynell A (1995) Widespread and lateralized effects of acute traumatic brain injury on norepinephrine turnover in the rat brain. Brain Res 674(2):307\u2013313. https:\/\/doi.org\/10.1016\/0006-8993(95)00032-L","journal-title":"Brain Res"},{"issue":"2","key":"4706_CR141","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0006-8993(98)00524-1","volume":"800","author":"AA Dunn-Meynell","year":"1998","unstructured":"Dunn-Meynell AA, Hassanain M, Levin BE (1998) Norepinephrine and traumatic brain injury: a possible role in post-traumatic edema. Brain Res 800(2):245\u2013252. https:\/\/doi.org\/10.1016\/S0006-8993(98)00524-1","journal-title":"Brain Res"},{"issue":"1","key":"4706_CR142","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-8993(94)90842-7","volume":"660","author":"A Dunn-Meynell","year":"1994","unstructured":"Dunn-Meynell A, Shijun P, Levin BE (1994) Focal traumatic brain injury causes widespread reductions in rat brain norepinephrine turnover from 6 to 24 h. Brain Res 660(1):88\u201395. https:\/\/doi.org\/10.1016\/0006-8993(94)90842-7","journal-title":"Brain Res"},{"issue":"1","key":"4706_CR143","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1179\/016164103101201094","volume":"25","author":"T Fujinaka","year":"2003","unstructured":"Fujinaka T, Kohmura E, Yuguchi T, Yoshimine T (2003) The morphological and neurochemical effects of diffuse brain injury on rat central noradrenergic system. Neurol Res 25(1):35\u201341. https:\/\/doi.org\/10.1179\/016164103101201094","journal-title":"Neurol Res"},{"issue":"3","key":"4706_CR144","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/neu.1992.9.269","volume":"9","author":"MR Prasad","year":"1992","unstructured":"Prasad MR, Tzigaret CM, Smith D, Soares H, McIntosh TK (1992) Decreased \u03b11-Adrenergic Receptors After Experimental Brain Injury. J Neurotrauma 9(3):269\u2013279. https:\/\/doi.org\/10.1089\/neu.1992.9.269","journal-title":"J Neurotrauma"},{"issue":"1","key":"4706_CR145","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0006-8993(86)91112-1","volume":"370","author":"R Cash","year":"1986","unstructured":"Cash R, Raisman R, Lanfumey L, Ploska A, Agid Y (1986) Cellular localization of adrenergic receptors in rat and human brain. Brain Res 370(1):127\u2013135. https:\/\/doi.org\/10.1016\/0006-8993(86)91112-1","journal-title":"Brain Res"},{"issue":"2","key":"4706_CR146","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0006-8993(84)90117-3","volume":"322","author":"R Cash","year":"1984","unstructured":"Cash R, Ruberg M, Raisman R, Agid Y (1984) Adrenergic receptors in Parkinson\u2019s disease. Brain Res 322(2):269\u2013275. https:\/\/doi.org\/10.1016\/0006-8993(84)90117-3","journal-title":"Brain Res"},{"key":"4706_CR147","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuroscience.2010.10.048","volume":"172","author":"N Kobori","year":"2011","unstructured":"Kobori N, Hu B, Dash PK (2011) Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory dysfunction. Neuroscience 172:293\u2013302. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.10.048","journal-title":"Neuroscience"},{"issue":"7556","key":"4706_CR148","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A et al (2015) [alpia]-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature (London) 522(7556):340. https:\/\/doi.org\/10.1038\/nature14547","journal-title":"Nature (London)"},{"issue":"5321","key":"4706_CR149","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the \u03b1-Synuclein Gene Indentified in Families with Parkinson\u2019s Disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"2","key":"4706_CR150","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T et al (1998) AlaSOPro mutation in the gene encoding \u03b1-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108. https:\/\/doi.org\/10.1038\/ng0298-106","journal-title":"Nat Genet"},{"issue":"2","key":"4706_CR151","first-page":"367","volume":"152","author":"A Takeda","year":"1998","unstructured":"Takeda A, Mallory M, Sundsmo M, Honer W et al (1998) Abnormal accumulation of (NACP\/alpha-synuclein) in neurodegenerative disorders. Am J Pathol 152(2):367","journal-title":"Am J Pathol"},{"issue":"4","key":"4706_CR152","first-page":"879","volume":"152","author":"B Minami","year":"1998","unstructured":"Minami B, Nakajo S, Pang-Hsien T, Tomita T et al (1998) Aggregation of (Alpha-synuclein) in lewy bodies of sporadic Parkinson\u2019s disease and dementia with lewy bodies. Am J Pathol 152(4):879\u201384","journal-title":"Am J Pathol"},{"issue":"4","key":"4706_CR153","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","volume":"57","author":"MC Irizarry","year":"1998","unstructured":"Irizarry MC, Growdon W, Gomez-isla T, Newell K, George JM, Clayton DF, Hyman BT (1998) Nigral and cortical lewy bodies and dystrophic nigral neurites in parkinson\u02bcs disease and cortical lewy body disease contain \u03b1-synuclein immunoreactivity. J Neuropathol Exp Neurol 57(4):334\u2013337. https:\/\/doi.org\/10.1097\/00005072-199804000-00005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"4706_CR154","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/sj.mp.4000446","volume":"3","author":"E Mezey","year":"1998","unstructured":"Mezey E, Dehejia AM, Harta G, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH (1998) Alpha synuclein is present in Lewy bodies in sporadic Parkinson\u2019s disease. Mol Psychiatry 3(6):493\u2013499. https:\/\/doi.org\/10.1038\/sj.mp.4000446","journal-title":"Mol Psychiatry"},{"issue":"11","key":"4706_CR155","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci 95(11):6469\u20136473. https:\/\/doi.org\/10.1073\/pnas.95.11.6469","journal-title":"Proc Natl Acad Sci"},{"key":"4706_CR156","doi-asserted-by":"publisher","unstructured":"Chang, C-W, Yang, S-Y, Yang, C-C, Chang, C-W, and Wu, Y-R (2020) Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease. Frontiers in Neurology 10. https:\/\/doi.org\/10.3389\/fneur.2019.01388.","DOI":"10.3389\/fneur.2019.01388"},{"issue":"4","key":"4706_CR157","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/mds.22928","volume":"25","author":"R Duran","year":"2010","unstructured":"Duran R, Barrero FJ, Morales B, Luna JD, Ramirez M, Vives F (2010) Plasma \u03b1-synuclein in patients with Parkinson\u2019s disease with and without treatment. Mov Disord 25(4):489\u2013493. https:\/\/doi.org\/10.1002\/mds.22928","journal-title":"Mov Disord"},{"issue":"3","key":"4706_CR158","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OMA El-Agnaf","year":"2006","unstructured":"El-Agnaf OMA, Salem SA, Paleologou KE et al (2006) Detection of oligomeric forms of \u03b1-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J 20(3):419\u2013425. https:\/\/doi.org\/10.1096\/fj.03-1449com","journal-title":"FASEB J"},{"issue":"1","key":"4706_CR159","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/srep02540","volume":"3","author":"PG Foulds","year":"2013","unstructured":"Foulds PG, Diggle P, Mitchell JD et al (2013) A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease. Sci Rep 3(1):2540. https:\/\/doi.org\/10.1038\/srep02540","journal-title":"Sci Rep"},{"issue":"12","key":"4706_CR160","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1096\/fj.10-179192","volume":"25","author":"PG Foulds","year":"2011","unstructured":"Foulds PG, Mitchell JD, Parker A et al (2011) Phosphorylated \u03b1-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson\u2019s disease. FASEB J 25(12):4127\u20134137. https:\/\/doi.org\/10.1096\/fj.10-179192","journal-title":"FASEB J"},{"issue":"20","key":"4706_CR161","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","volume":"75","author":"T Tokuda","year":"2010","unstructured":"Tokuda T, Qureshi M, Ardah M et al (2010) Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75(20):1766\u20131772. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fd613b","journal-title":"Neurology"},{"issue":"3","key":"4706_CR162","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/alzrt255","volume":"6","author":"O Hansson","year":"2014","unstructured":"Hansson O, Hall S, \u00d6hrfelt A et al (2014) Levels of cerebrospinal fluid \u03b1-synuclein oligomers are increased in Parkinson\u2019s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 6(3):25. https:\/\/doi.org\/10.1186\/alzrt255","journal-title":"Alzheimer's Res Ther"},{"issue":"1","key":"4706_CR163","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","volume":"287","author":"R Borghi","year":"2000","unstructured":"Borghi R, Marchese R, Negro A et al (2000) Full length \u03b1-synuclein is present in cerebrospinal fluid from Parkinson\u2019s disease and normal subjects. Neurosci Lett 287(1):65\u201367. https:\/\/doi.org\/10.1016\/S0304-3940(00)01153-8","journal-title":"Neurosci Lett"},{"issue":"3","key":"4706_CR164","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neulet.2008.11.015","volume":"450","author":"A \u00d6hrfelt","year":"2009","unstructured":"\u00d6hrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, Blennow K, Zetterberg H (2009) Cerebrospinal fluid \u03b1-synuclein in neurodegenerative disorders\u2014A marker of synapse loss? Neurosci Lett 450(3):332\u2013335. https:\/\/doi.org\/10.1016\/j.neulet.2008.11.015","journal-title":"Neurosci Lett"},{"issue":"2","key":"4706_CR165","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","volume":"213","author":"B Mollenhauer","year":"2008","unstructured":"Mollenhauer B, Cullen V, Kahn I et al (2008) Direct quantification of CSF \u03b1-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213(2):315\u2013325. https:\/\/doi.org\/10.1016\/j.expneurol.2008.06.004","journal-title":"Exp Neurol"},{"issue":"2","key":"4706_CR166","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waragai M et al (2017) Development of a Biochemical Diagnosis of Parkinson Disease by Detection of \u03b1-Synuclein Misfolded Aggregates in Cerebrospinal Fluid. JAMA Neurol 74(2):163\u2013172. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4547","journal-title":"JAMA Neurol"},{"issue":"9","key":"4706_CR167","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/mds.27806","volume":"34","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer B, Caspell-Garcia CJ, Coffey CS et al (2019) Longitudinal analyses of cerebrospinal fluid \u03b1-Synuclein in prodromal and early Parkinson\u2019s disease. Mov Disord 34(9):1354\u20131364. https:\/\/doi.org\/10.1002\/mds.27806","journal-title":"Mov Disord"},{"key":"4706_CR168","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.brainresbull.2016.12.003","volume":"133","author":"D Rokad","year":"2016","unstructured":"Rokad D, Ghaisas S, Harischandra DS, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2016) Role of neurotoxicants and traumatic brain injury in \u03b1-synuclein protein misfolding and aggregation. Brain Res Bull 133:60\u201370. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.12.003","journal-title":"Brain Res Bull"},{"key":"4706_CR169","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S (2012) Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18:S210\u2013S212. https:\/\/doi.org\/10.1016\/S1353-8020(11)70065-7","journal-title":"Parkinsonism Relat Disord"},{"key":"4706_CR170","doi-asserted-by":"publisher","unstructured":"Post, MR, Lieberman, OJ, and Mosharov, EV (2018) Can Interactions Between \u03b1-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease? Frontiers in Neuroscience 12.https:\/\/doi.org\/10.3389\/fnins.2018.00161.","DOI":"10.3389\/fnins.2018.00161"},{"issue":"8","key":"4706_CR171","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","volume":"10","author":"VR Osterberg","year":"2015","unstructured":"Osterberg VR, Spinelli KJ, Weston LJ, Luk KC, Woltjer RL, Unni VK (2015) Progressive Aggregation of Alpha-Synuclein and Selective Degeneration of Lewy Inclusion-Bearing Neurons in a Mouse Model of Parkinsonism. Cell Rep 10(8):1252\u20131260. https:\/\/doi.org\/10.1016\/j.celrep.2015.01.060","journal-title":"Cell Rep"},{"key":"4706_CR172","doi-asserted-by":"publisher","unstructured":"Klann, EM, Dissanayake, U, Gurrala, A et al (2022) The Gut\u2013Brain Axis and Its Relation to Parkinson\u2019s Disease: A Review. Frontiers in Aging Neuroscience 13.https:\/\/doi.org\/10.3389\/fnagi.2021.782082.","DOI":"10.3389\/fnagi.2021.782082"},{"key":"4706_CR173","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3233\/JPD-191721","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer P, Van Den Berge N (2019) Brain-first versus gut-first parkinson\u2019s disease: a hypothesis. J Parkinsons Dis 9:281\u2013295","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"4706_CR174","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/ejn.15892","volume":"57","author":"LS Chiu","year":"2023","unstructured":"Chiu LS, Anderton RS (2023) The role of the microbiota\u2013gut\u2013brain axis in long-term neurodegenerative processes following traumatic brain injury. Eur J Neurosci 57(2):400\u2013418. https:\/\/doi.org\/10.1111\/ejn.15892","journal-title":"Eur J Neurosci"},{"issue":"2","key":"4706_CR175","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VMY (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20(2):130\u2013138. https:\/\/doi.org\/10.1038\/nm.3457","journal-title":"Nat Med"},{"issue":"20","key":"4706_CR176","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T et al (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838\u20136851. https:\/\/doi.org\/10.1523\/JNEUROSCI.5699-09.2010","journal-title":"J Neurosci"},{"issue":"1","key":"4706_CR177","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP et al (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7(1):42\u201342. https:\/\/doi.org\/10.1186\/1750-1326-7-42","journal-title":"Mol Neurodegener"},{"issue":"5","key":"4706_CR178","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VMY (2012) Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med 209(5):975\u2013986. https:\/\/doi.org\/10.1084\/jem.20112457","journal-title":"J Exp Med"},{"issue":"6109","key":"4706_CR179","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VMY (2012) Pathological \u03b1-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice. Science (American Assoc Adv Sci) 338(6109):949\u2013953. https:\/\/doi.org\/10.1126\/science.1227157","journal-title":"Science (American Assoc Adv Sci)"},{"issue":"1","key":"4706_CR180","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin D, Zhang YP, Lobanova E et al (2022) Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat Commun 13(1):5512. https:\/\/doi.org\/10.1038\/s41467-022-33252-6","journal-title":"Nat Commun"},{"issue":"10","key":"4706_CR181","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Majic SK et al (2011) In vivo demonstration that a-synuclein oligomers are toxic. Proc Natl Acad Sci 108(10):4194\u20134199","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"4706_CR182","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI43366","volume":"121","author":"C Hansen","year":"2011","unstructured":"Hansen C, Angot E, Bergstr\u00f6m A-L et al (2011) \u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Investig 121(2):715\u2013725. https:\/\/doi.org\/10.1172\/JCI43366","journal-title":"J Clin Investig"},{"issue":"32","key":"4706_CR183","doi-asserted-by":"publisher","first-page":"13482","DOI":"10.1074\/jbc.M117.780296","volume":"292","author":"RJ Karpowicz","year":"2017","unstructured":"Karpowicz RJ, Haney CM, Mihaila TS, Sandler RM, Petersson EJ, Lee VMY (2017) Selective imaging of internalized proteopathic \u03b1-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies. J Biol Chem 292(32):13482\u201313497. https:\/\/doi.org\/10.1074\/jbc.M117.780296","journal-title":"J Biol Chem"},{"issue":"31","key":"4706_CR184","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee H-J, Bae E-J et al (2009) Inclusion Formation and Neuronal Cell Death through Neuron-to-Neuron Transmission of \u03b1-Synuclein. Proceed Nat Acad Sci - PNAS 106(31):13010\u201313015. https:\/\/doi.org\/10.1073\/pnas.0903691106","journal-title":"Proceed Nat Acad Sci - PNAS"},{"issue":"4","key":"4706_CR185","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt EC, Maynard N, Clancy EK et al (2012) Neuron-to-neuron transmission of \u03b1-synuclein fibrils through axonal transport. Ann Neurol 72(4):517\u2013524. https:\/\/doi.org\/10.1002\/ana.23747","journal-title":"Ann Neurol"},{"issue":"5","key":"4706_CR186","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14(5):504\u20136. https:\/\/doi.org\/10.1038\/nm1747","journal-title":"Nat Med"},{"issue":"5","key":"4706_CR187","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14(5):501\u20133. https:\/\/doi.org\/10.1038\/nm1746","journal-title":"Nat Med"},{"issue":"Pt 4","key":"4706_CR188","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M et al (2013) Prion-like spreading of pathological \u03b1-synuclein in brain. Brain\u202f: a journal of neurology 136(Pt 4):1128\u20131138. https:\/\/doi.org\/10.1093\/brain\/awt037","journal-title":"Brain : a journal of neurology"},{"issue":"1","key":"4706_CR189","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.expneurol.2004.05.022","volume":"190","author":"JR Stone","year":"2004","unstructured":"Stone JR, Okonkwo DO, Dialo AO, Rubin DG, Mutlu LK, Povlishock JT, Helm GA (2004) Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp Neurol 190(1):59\u201369. https:\/\/doi.org\/10.1016\/j.expneurol.2004.05.022","journal-title":"Exp Neurol"},{"issue":"12","key":"4706_CR190","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/00005072-199912000-00007","volume":"58","author":"KL Newell","year":"1999","unstructured":"Newell KL, Boyer P, Gomez-Tortosa E, Hobbs W, Hedley-Whyte ET, Vonsattel JP, Hyman BT (1999) \u03b1-Synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol 58(12):1263\u20131268. https:\/\/doi.org\/10.1097\/00005072-199912000-00007","journal-title":"J Neuropathol Exp Neurol"},{"issue":"18","key":"4706_CR191","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/WNL.0b013e3182904d43","volume":"80","author":"S Mondello","year":"2013","unstructured":"Mondello S, Buki A, Italiano D, Jeromin A (2013) \u03b1-Synuclein in CSF of patients with severe traumatic brain injury. Neurology 80(18):1662\u20131668. https:\/\/doi.org\/10.1212\/WNL.0b013e3182904d43","journal-title":"Neurology"},{"issue":"5\u20136","key":"4706_CR192","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000321342","volume":"32","author":"E Su","year":"2010","unstructured":"Su E, Bell MJ, Wisniewski SR et al (2010) \u03b1-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia. Dev Neurosci 32(5\u20136):385\u2013395. https:\/\/doi.org\/10.1159\/000321342","journal-title":"Dev Neurosci"},{"issue":"3","key":"4706_CR193","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jshs.2022.11.007","volume":"12","author":"R Vorn","year":"2023","unstructured":"Vorn R, Devoto C, Meier TB et al (2023) Are EPB41 and alpha-synuclein diagnostic biomarkers of sport-related concussion? Findings from the NCAA and Department of Defense CARE Consortium. J Sport Health Sci 12(3):379\u2013387. https:\/\/doi.org\/10.1016\/j.jshs.2022.11.007","journal-title":"J Sport Health Sci"},{"key":"4706_CR194","doi-asserted-by":"publisher","unstructured":"Ye, L, Zhang, D, Shao, M et al (2019) Lower Posttraumatic \u03b1-Synuclein Level Associated With Altered Default Mode Network Connectivity Following Acute Mild Traumatic Brain Injury. Frontiers in Neural Circuits 13.https:\/\/doi.org\/10.3389\/fncir.2019.00026.","DOI":"10.3389\/fncir.2019.00026"},{"issue":"9","key":"4706_CR195","doi-asserted-by":"publisher","first-page":"e1126","DOI":"10.1212\/wnl.0000000000010087","volume":"95","author":"CB Peltz","year":"2020","unstructured":"Peltz CB, Kenney K, Gill J, Diaz-Arrastia R, Gardner RC, Yaffe K (2020) Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans. Neurology 95(9):e1126\u2013e1133. https:\/\/doi.org\/10.1212\/wnl.0000000000010087","journal-title":"Neurology"},{"issue":"1","key":"4706_CR196","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0014-4886(03)00245-0","volume":"184","author":"K Uryu","year":"2003","unstructured":"Uryu K, Giasson BI, Longhi L et al (2003) Age-dependent synuclein pathology following traumatic brain injury in mice. Exp Neurol 184(1):214\u2013224. https:\/\/doi.org\/10.1016\/S0014-4886(03)00245-0","journal-title":"Exp Neurol"},{"issue":"4","key":"4706_CR197","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jalz.2017.11.003","volume":"14","author":"ML Nogueira","year":"2018","unstructured":"Nogueira ML, Hamraz M, Abolhassani M et al (2018) Mechanical stress increases brain amyloid \u03b2, tau, and \u03b1-synuclein concentrations in wild-type mice. Alzheimers Dement 14(4):444\u2013453. https:\/\/doi.org\/10.1016\/j.jalz.2017.11.003","journal-title":"Alzheimers Dement"},{"issue":"1","key":"4706_CR198","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12035-020-02123-w","volume":"58","author":"SW Carlson","year":"2021","unstructured":"Carlson SW, Yan HQ, Li Y et al (2021) Differential regional responses in soluble monomeric alpha synuclein abundance following traumatic brain injury. Mol Neurobiol 58(1):362\u2013374. https:\/\/doi.org\/10.1007\/s12035-020-02123-w","journal-title":"Mol Neurobiol"},{"key":"4706_CR199","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2377-10-102","volume":"10","author":"A Colantonio","year":"2010","unstructured":"Colantonio A, Harris JE, Ratcliff G, Chase S, Ellis K (2010) Gender differences in self reported long term outcomes following moderate to severe traumatic brain injury. BMC Neurol 10:102. https:\/\/doi.org\/10.1186\/1471-2377-10-102","journal-title":"BMC Neurol"},{"key":"4706_CR200","doi-asserted-by":"publisher","unstructured":"Beheshti, I, Booth, S, and Ko, JH (2024) Differences in brain aging between sexes in Parkinson\u2019s disease. npj Parkinson's Disease 10(1): 35.https:\/\/doi.org\/10.1038\/s41531-024-00646-w.","DOI":"10.1038\/s41531-024-00646-w"},{"key":"4706_CR201","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.parkreldis.2019.10.019","volume":"69","author":"DS Abraham","year":"2019","unstructured":"Abraham DS, Gruber-Baldini AL, Magder LS et al (2019) Sex differences in Parkinson\u2019s disease presentation and progression. Parkinsonism Relat Disord 69:48\u201354. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.019","journal-title":"Parkinsonism Relat Disord"},{"issue":"22","key":"4706_CR202","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1089\/neu.2018.6171","volume":"36","author":"R Gupte","year":"2019","unstructured":"Gupte R, Brooks W, Vukas R, Pierce J, Harris J (2019) Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know. J Neurotrauma 36(22):3063\u20133091. https:\/\/doi.org\/10.1089\/neu.2018.6171","journal-title":"J Neurotrauma"},{"issue":"6","key":"4706_CR203","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1089\/neu.2005.22.669","volume":"22","author":"ED Hall","year":"2005","unstructured":"Hall ED, Gibson TR, Pavel KM (2005) Lack of a gender difference in post-traumatic neurodegeneration in the mouse controlled cortical impact injury model. J Neurotrauma 22(6):669\u2013679. https:\/\/doi.org\/10.1089\/neu.2005.22.669","journal-title":"J Neurotrauma"},{"issue":"1","key":"4706_CR204","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0014-4886(02)00048-1","volume":"180","author":"NC Kupina","year":"2003","unstructured":"Kupina NC, Detloff MR, Bobrowski WF, Snyder BJ, Hall ED (2003) Cytoskeletal protein degradation and neurodegeneration evolves differently in males and females following experimental head injury. Exp Neurol 180(1):55\u201373. https:\/\/doi.org\/10.1016\/S0014-4886(02)00048-1","journal-title":"Exp Neurol"},{"issue":"14","key":"4706_CR205","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1089\/neu.2017.5547","volume":"35","author":"A Jullienne","year":"2018","unstructured":"Jullienne A, Salehi A, Affeldt B et al (2018) Male and female mice exhibit divergent responses of the cortical vasculature to traumatic brain injury. J Neurotrauma 35(14):1646\u20131658. https:\/\/doi.org\/10.1089\/neu.2017.5547","journal-title":"J Neurotrauma"},{"key":"4706_CR206","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jneumeth.2015.10.002","volume":"257","author":"R Mychasiuk","year":"2016","unstructured":"Mychasiuk R, Hehar H, Candy S, Ma I, Esser MJ (2016) The direction of the acceleration and rotational forces associated with mild traumatic brain injury in rodents effect behavioural and molecular outcomes. J Neurosci Methods 257:168\u2013178. https:\/\/doi.org\/10.1016\/j.jneumeth.2015.10.002","journal-title":"J Neurosci Methods"},{"key":"4706_CR207","doi-asserted-by":"publisher","unstructured":"Ye, C, Ho, R, Moberg, KH, and Zheng, JQ (2024) Adverse impact of female reproductive signaling on age-dependent neurodegeneration after mild head trauma in Drosophila. eLife 13: RP97908. https:\/\/doi.org\/10.7554\/eLife.97908.","DOI":"10.7554\/eLife.97908"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04706-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04706-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04706-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:45:35Z","timestamp":1747194335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04706-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":207,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4706"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04706-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}